메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Eiko Saitoh Aoki (Mita Hospital) Kumiko Saika (National Cancer Center Tokyo) Kazushige Kiguchi (Tokyo Health Service Association Tokyo Japan) Tohru Morisada (Faculty of Medicine Kyorin University Tokyo Japan) Daisuke Aoki (Keio University School of Medicine)
저널정보
대한부인종양학회 Journal of Gynecologic Oncology Journal of Gynecologic Oncology Vol.34 No.2
발행연도
2023.3
수록면
1 - 9 (9page)
DOI
https://doi.org/10.3802/jgo.2023.34.e14

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective: In Japan, cer vical cancer screening consists of a cytology examination performedonce ever y 2 years. We verified whether the risk of cer vical intraepithelial neoplasia (CIN)3 disease or higher (CIN3+) was equivalent to that of cytology negative cases (negative forintraepithelial lesion or malignancy [NILM]) for patients with a cytological diagnosis of“atypical squamous cells of undetermined significance (ASC-US)” who tested negative forhuman papillomavirus (HPV). Methods: Data from a total of 22,925 cases who had undergone cer vical cancer screening atleast twice or who had completed follow-up examinations after cer vical screening at a singlefacility between April 2013 and April 2018 were analyzed. The cumulative incidence of CIN3+was calculated for each categor y of initial cytology finding and HPV result (NILM, > ASC-US,ASC-US/HPV (unknown), ASC-US/HPV+, and ASC-US/HPV−). The statistical analysis wasconducted using the Cox proportional hazards model. Results: The hazard ratio for the cumulative incidence of CIN3+ in 2 years relative to that forNILM cases was 2.7 (95% confidence inter val=1.0–7.8) for > ASC-US cases, 0.5 (0.1–1.7) forASC-US/HPV (unknown), 0.8 (0.3–2.4) for ASC-US/HPV+ cases, and 0.3 (0.1–1.0) for ASC-US/HPV− cases. Conclusion: Because the cumulative incidence of CIN3+ at 2 years for the ASC-US/HPV− caseswas sufficiently low, compared with that of the NILM cases, we considered it reasonable andsafe to perform HPV triage for ASC-US cases and to allow HPV-negative cases to return fortheir next screening in 2 years, which is the same follow-up schedule as that for NILM cases.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0